● DAMMNEWS STORY INTEL • ROUTE A LOCAL/FREE • NO PAID AI API ●
DAMMNEWS®
Independent aggregation • v2.4.14 • 2026-08-06

NEARLY 200 DEATHS LINKED TO WEIGHT-LOSS DRUGS OZEMPIC AND MOUNJARO IN THE UK

1 min read • 1 hr ago • Times of India • [src]
SOURCE SPECTRUM: The Times of India Unrated
LEFTCENTRERIGHTUNRATED
Third-party classification: Not ratedmethod and full source list. Bias is not a truth score.
REPORT A PROBLEM WITH THIS SOURCE
Reports are reviewed by the DAMMNEWS administrator. Please do not include personal or sensitive information.

SOURCE AGREEMENT & OPEN QUESTIONS

WHAT SOURCES AGREE ON
One linked publisher is currently carrying this report in the live cache.

WHAT REMAINS UNCLEAR
RSS excerpts are short and may omit qualifications, timing or attribution. Read the original reports before treating a detail as settled.

WHERE REPORTING MAY DIFFER
Independent comparison coverage has not yet been identified in the current live cache.

SOURCE COMPARISON

SourceLatest linked headlineAge
Times of IndiaNEARLY 200 DEATHS LINKED TO WEIGHT-LOSS DRUGS OZEMPIC AND MOUNJARO IN THE UK1 hr ago

WHAT HAPPENED

UK health authorities have recorded almost 200 fatalities linked to the anti-obesity medications Mounjaro and Wegovy. These drugs have been associated with more than 150,000 adverse effects.

Times of India reports that uK health authorities have recorded almost 200 fatalities linked to the anti-obesity medications Mounjaro and Wegovy.

The report adds: These drugs have been associated with more than 150,000 adverse effects.

Notably, semaglutide, which is marketed as Ozempic and Wegovy, accounts for 59 deaths, while tirzepatide, known as Mounjaro, has resulted in 120 deaths and over 106,000 adverse reactions, and liraglutide, or Saxenda,…

This report is covered across the current DAMMNEWS feeds. Health reports can affect personal decisions, so the source, study size and official guidance matter more than a short headline alone.

This is a developing report. DAMMNEWS will surface related coverage as closely matched reporting enters the live cache.

DAMMNEWS RSS BRIEFING — generated locally from the available Times of India headline and RSS excerpt. It is not a summary of the full source article.

ADVERTISEMENT

RELATED DAMMNEWS COVERAGE

Built locally from the available RSS excerpts for this story and closely related DAMMNEWS coverage. Statements are attributed to their feed source; no paid AI API was used. Short excerpts can omit important context, so the original source remains essential.
READ FULL AT SOURCE →
ADVERTISEMENT
TEXT MODE PRINT SHARE: X Facebook Email ← Front page
ADVERTISEMENT
DAMMNEWS® 2026 • Local rules-based story intelligence • Original source remains one click away
RSSSource SpectrumAboutPrivacyContactTerms